Prostate Cancer Services

Prostate cancer is the second most commonly diagnosed cancer among men, behind only skin cancer. It is the second leading cause of cancer death among men, after lung cancer.

The American Cancer Society estimates that one in six men will be diagnosed with prostate cancer at some point in his lifetime. However, because of earlier diagnosis and ever-improving treatments, the chances of surviving prostate cancer are improving.

At the UC Irvine Health Center for Urological Care, our prostate specialists are renowned for their expertise in robot-assisted, minimally invasive prostate cancer surgery. We also have pioneered the use of hypothermic cooling during robot-assisted prostatectomy to reduce and even prevent secondary side effects of inflammation and nerve damage.

Many patients are concerned that treatment for prostate cancer will cause urinary incontinence and sexual dysfunction. UC Irvine Health physicians are dedicated to reducing the risks of these troubling side effects by using — and continuing to develop — the latest innovations in surgical, radiation and medical treatment.

To make an appointment, call us at 714-456-6068.

Annual prostate cancer screening is recommend for men beginning at age 50 with a rectal exam and a blood test for prostate-specific antigen (PSA).

A high PSA level can be an indicator of prostate cancer. But it can also indicated an enlarged prostate. In addition, some men who have prostate cancer do not have elevated PSA levels.

It is best to consult with your physician if you have an elevated PSA.

We offer the following cancer treatments and services:

Learn the signs and symptoms of prostate cancer ›

View a video about prostate cancer ›

UC Irvine Medical Center was the first institution in Southern California to offer minimally invasive, robot-assisted prostatectomy using the da Vinci Surgical System®, and is a national leader in laparoscopic surgery using the Karl Storz OR1 operating room technology.

Beginning in 2008, Dr. Thomas E. Ahlering, director of the UC Irvine Health Robotic Oncology Center, developed a patented method called hypothermic robot-assisted radical prostatectomy to cool the urinary tract and nerves surrounding the prostate gland and prevent injury. Learn more about hypothermic robot-assisted radical prostatectomy ›

Combining these procedures produces excellent results for our patients, including reduced blood loss, nearly zero blood transfusion, low complication rates and an earlier return to work. Three months after surgery, 80 percent of patients have regained urinary control, with 95 percent achieving control within a year.

Make an Appointment

714-456-6068